Daniel R. Chevallard - Jan 9, 2025 Form 4 Insider Report for LENZ Therapeutics, Inc. (LENZ)

Role
Chief Financial Officer
Signature
/s/ Daniel R. Chevallard
Stock symbol
LENZ
Transactions as of
Jan 9, 2025
Transactions value $
$0
Form type
4
Date filed
1/13/2025, 05:22 PM
Previous filing
May 15, 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LENZ Stock Option (right to buy) Award $0 +70.4K $0.00 70.4K Jan 9, 2025 Common Stock 70.4K $26.34 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2024 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one (1) year anniversary of the Vesting Commencement Date, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). "Vesting Commencement Date" shall mean January 9, 2025.

Remarks:

Exhibit 24 - Power of Attorney